Opko Health Inc (OPK) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Opko Health Inc (OPK) has a cash flow conversion efficiency ratio of -0.027x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-34.65 Million) by net assets ($1.31 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Opko Health Inc - Cash Flow Conversion Efficiency Trend (1995–2024)
This chart illustrates how Opko Health Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Opko Health Inc balance sheet liabilities for a breakdown of total debt and financial obligations.
Opko Health Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Opko Health Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Aditya Birla Fashion and Retail Limited
NSE:ABFRL
|
-0.015x |
|
Benakat Petroleum Energy
JK:BIPI
|
0.004x |
|
Inspur Software Co Ltd
SHG:600756
|
-0.039x |
|
Bide Pharmatech Co. Ltd. A
SHG:688073
|
N/A |
|
R&S GROUP HOLDING AG
SW:RSGN
|
2.091x |
|
Patria Investments Ltd
NASDAQ:PAX
|
0.103x |
|
We Buy Cars Hlds Ltd
JSE:WBC
|
N/A |
|
Hexatronic Group AB
ST:HTRO
|
0.101x |
Annual Cash Flow Conversion Efficiency for Opko Health Inc (1995–2024)
The table below shows the annual cash flow conversion efficiency of Opko Health Inc from 1995 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Opko Health Inc.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $1.37 Billion | $-183.49 Million | -0.134x | -562.07% |
| 2023-12-31 | $1.39 Billion | $-28.20 Million | -0.020x | +66.70% |
| 2022-12-31 | $1.56 Billion | $-95.19 Million | -0.061x | -367.93% |
| 2021-12-31 | $1.69 Billion | $38.34 Million | 0.023x | -3.67% |
| 2020-12-31 | $1.67 Billion | $39.48 Million | 0.024x | +122.10% |
| 2019-12-31 | $1.61 Billion | $-172.52 Million | -0.107x | -75.35% |
| 2018-12-31 | $1.79 Billion | $-109.14 Million | -0.061x | -21.99% |
| 2017-12-31 | $1.84 Billion | $-92.08 Million | -0.050x | -426.02% |
| 2016-12-31 | $2.09 Billion | $32.05 Million | 0.015x | -81.51% |
| 2015-12-31 | $1.98 Billion | $164.02 Million | 0.083x | +176.62% |
| 2014-12-31 | $835.80 Million | $-90.38 Million | -0.108x | -62.22% |
| 2013-12-31 | $872.98 Million | $-58.19 Million | -0.067x | +46.68% |
| 2012-12-31 | $203.28 Million | $-25.41 Million | -0.125x | -8.73% |
| 2011-12-31 | $160.88 Million | $-18.50 Million | -0.115x | +86.12% |
| 2010-12-31 | $23.05 Million | $-19.09 Million | -0.828x | -104.90% |
| 2009-12-31 | $57.73 Million | $-23.34 Million | -0.404x | +99.50% |
| 2008-12-31 | $359.00K | $-29.29 Million | -81.599x | -7980.45% |
| 2007-12-31 | $16.78 Million | $-16.95 Million | -1.010x | -2574.56% |
| 2006-12-31 | $8.08 Million | $-305.00K | -0.038x | +63.28% |
| 2005-12-31 | $8.72 Million | $-897.00K | -0.103x | +36.41% |
| 2004-12-31 | $9.83 Million | $-1.59 Million | -0.162x | +71.45% |
| 2003-12-31 | $10.30 Million | $-5.84 Million | -0.566x | -3.00% |
| 2002-12-31 | $16.07 Million | $-8.84 Million | -0.550x | -79.44% |
| 2001-12-31 | $26.12 Million | $-8.01 Million | -0.306x | -119.84% |
| 2000-12-31 | $35.77 Million | $-4.99 Million | -0.139x | +88.80% |
| 1999-12-31 | $2.59 Million | $-3.23 Million | -1.245x | -216.43% |
| 1998-12-31 | $6.10 Million | $-2.40 Million | -0.393x | +85.08% |
| 1997-12-31 | $1.10 Million | $-2.90 Million | -2.636x | -142.55% |
| 1996-12-31 | $2.30 Million | $-2.50 Million | -1.087x | -171.74% |
| 1995-12-31 | $5.00 Million | $-2.00 Million | -0.400x | -- |
About Opko Health Inc
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offer laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, m… Read more